Generali Investments Cee, Investicni Spolecnost, A.S. Bristol Myers Squibb CO Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $1.07 Trillion
- Q1 2025
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 17,900 shares of BMY stock, worth $864,212. This represents 0.1% of its overall portfolio holdings.
Number of Shares
17,900
Previous 17,900
-0.0%
Holding current value
$864,212
Previous $1.01 Billion
7.83%
% of portfolio
0.1%
Previous 0.1%
Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,809Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.24 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.66 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.22 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.58 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.21 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $103B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...